title: Malaria vaccine can prevent millions of deaths in the world.
abstract: Malaria is a major public health problem, afflicting ~36% of the world's population. The World Health Organization (WHO) has estimated that there were 216 million cases of malaria in 2010, and ~655,000 people died from the disease (~2000 per day), many under age five. Yet the disease, a killer for centuries, remains endemic in many poor nations, particularly in Africa, where it is blamed for retarding economic growth. India contributes ~70% of the 2.5 million reported cases in Southeast Asia. Malaria is also an important threat to travelers to the tropics, causing thousands of cases of illness and occasional deaths. The 5 Plasmodium species known to cause malaria are P. falciparum, P. vivax, P. ovale, P. malariae and P. knowlesi. Most cases of malaria are uncomplicated, but some can quickly turn into severe, often fatal, episodes in vulnerable individuals if not promptly diagnosed and effectively treated. Malaria vaccines have been an area of intensive research, but there is no effective vaccine. Vaccines are among the most cost-effective tools for public health; they have historically contributed to a reduction in the spread and burden of infectious diseases. Many antigens present throughout the parasite life cycle that could be vaccine targets. More than 30 of these are being researched by teams worldwide in the hope of identifying a combination that can elicit protective immunity. Most vaccine research has focused on the P. falciparum strain due to its high mortality and the ease of conducting in vitro and in vivo studies. DNA-based vaccines are a new technology that may hold hope for an effective malaria vaccine.
authors: Department of Community Medicine; Pt. B.D. Sharma PGIMS; Rohtak, Haryana India.
authors: Ramesh
authors: R
authors: Verma
authors: Pardeep
authors: P
authors: Khanna
authors: Suraj
authors: S
authors: Chawla
mesh_terms: D055808:Drug Discovery / Q000639:trends*; D014943:Global Health; D006801:Humans; D008288:Malaria / Q000453:epidemiology* / Q000401:mortality* / Q000517:prevention & control; D017780:Malaria Vaccines / Q000276:immunology* / Q000302:isolation & purification*; D009026:Mortality
chemical_list: D017780:Malaria Vaccines
keywords: immunity; malaria; parasites; research; vaccines
references: Curr Med Chem. 2001 Dec;8(14):1713-26
references: 11562290
references: J Immunol Methods. 1996 May 27;191(2):131-42
references: 8666832
references: Nature. 2005 Mar 10;434(7030):214-7
references: 15759000
references: Expert Rev Vaccines. 2011 Dec;10(12):1697-708
references: 22085173
references: Am J Trop Med Hyg. 2007 Dec;77(6 Suppl):79-87
references: 18165478
references: Lancet. 2001 Dec 8;358(9297):1927-34
references: 11747915
references: Indian J Malariol. 1992 Sep;29(3):129-60
references: 1286730
references: Philos Trans R Soc Lond B Biol Sci. 2011 Oct 12;366(1579):2806-14
references: 21893544
references: Bull World Health Organ. 2000;78(12):1424-37
references: 11196489
references: Clin Diagn Lab Immunol. 2003 Jan;10(1):133-9
references: 12522051
references: Infect Immun. 1996 Sep;64(9):3833-44
references: 8751936
references: Parasite Immunol. 2003 Jul;25(7):351-9
references: 14521577
references: Nature. 1991 Aug 15;352(6336):595-600
references: 1865923
references: Immunity. 1998 Feb;8(2):177-87
references: 9491999
references: Nature. 2002 Oct 3;419(6906):498-511
references: 12368864
references: Lancet Infect Dis. 2004 Jun;4(6):327-36
references: 15172341
references: Ann Trop Med Parasitol. 1993 Dec;87(6):617-26
references: 8122925
references: Lancet. 2002 Oct 12;360(9340):1107
references: 12387952
references: Nature. 1961 Nov 25;192:733-7
references: 13880318
references: Sci Prog. 2009;92(Pt 1):1-38
references: 19544698
references: Crit Rev Biochem Mol Biol. 2002;37(1):29-54
references: 11905546